Literature DB >> 12926124

Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.

Hee Sung Kim1, Eun Kyung Hong, So Yeon Park, Woo Ho Kim, Hye Seung Lee.   

Abstract

beta-catenin plays an important role in the Wnt signaling pathway and the E-cadherin-catenin complex plays a critical role in the maintenance of normal tissue architecture. An alteration of any of the components of the E-cadherin-catenin complex is believed to result in the loss of cell-cell adhesion and to contribute to carcinogenesis. In order to evaluate such alterations in the gastric adenoma-carcinoma sequence, the abnormal expression of beta-catenin and E-cadherin and the mutations of beta-catenin exon 3 were studied. In the case of beta-catenin, nuclear immunoreactivity was noted in 17 (11.3%) out of 150 adenomas and 19 (17.1%) out of 111 carcinomas (p = 0.18). Among 51 gastric adenomas, no mutations were detected by direct sequencing analysis. The loss of membranous expression of both beta-catenin and E-cadherin linearly increased with tumor progression, however, beta-catenin loss was more frequent than E-cadherin. Our results show that the nuclear expression and membranous loss of beta-catenin without exon 3 mutation is relatively frequent in gastric adenomas. These suggest that alteration of other genes is primarily responsible for the nuclear translocation of beta-catenin in gastric adenomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926124

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Expression and Prognostic Significance of CDK8 and β-Catenin in Hepatocellular Carcinoma.

Authors:  Song Iy Han; Sung-Chul Lim
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.

Authors:  Nermeen S Youssef; Wesam M Osman
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells.

Authors:  Lydia E Wroblewski; M Blanca Piazuelo; Rupesh Chaturvedi; Michael Schumacher; Eitaro Aihara; Rui Feng; Jennifer M Noto; Alberto Delgado; Dawn A Israel; Yana Zavros; Marshall H Montrose; Noah Shroyer; Pelayo Correa; Keith T Wilson; Richard M Peek
Journal:  Gut       Date:  2014-08-14       Impact factor: 23.059

4.  FGF10 signaling controls stomach morphogenesis.

Authors:  Pia Nyeng; Gitte Anker Norgaard; Sune Kobberup; Jan Jensen
Journal:  Dev Biol       Date:  2006-11-17       Impact factor: 3.582

5.  Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of beta-catenin.

Authors:  Xiao-Xin Cheng; Zi-Chuang Wang; Xiao-Yan Chen; Yuan Sun; Qing-You Kong; Jia Liu; Xue Gao; Hong-Wei Guan; Hong Li
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

6.  Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.

Authors:  Ki Taek Nam; Hyuk-Joon Lee; Hoyin Mok; Judith Romero-Gallo; James E Crowe; Richard M Peek; James R Goldenring
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

7.  Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.

Authors:  Lidan Sun; Fei Chen; Wenna Shi; Lei Qi; Zhongmei Zhao; Jianping Zhang
Journal:  Diagn Pathol       Date:  2014-07-16       Impact factor: 2.644

8.  Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.

Authors:  T Aparicio; M Svrcek; A Zaanan; E Beohou; A Laforest; P Afchain; Emmanuel Mitry; J Taieb; F Di Fiore; J-M Gornet; A Thirot-Bidault; I Sobhani; D Malka; T Lecomte; C Locher; F Bonnetain; P Laurent-Puig
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

9.  E-cadherin and β-catenin adhesion proteins correlate positively with connexins in colorectal cancer.

Authors:  Luiza Kanczuga-Koda; Andrzej Wincewicz; Andrzej Fudala; Tomasz Abrycki; Waldemar Famulski; Marek Baltaziak; Stanislaw Sulkowski; Mariusz Koda
Journal:  Oncol Lett       Date:  2014-03-14       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.